Background: Clustered protocadherins (PCDHs) map in tandem at human chromosome 5q31 and comprise three multi-genes clusters: α-, β- and γ-PCDH. The expression of this cluster consists of a complex mechanism involving DNA hub formation through DNA-CCTC binding factor (CTCF) interaction. Methylation alterations can affect this interaction, leading to transcriptional dysregulation. In cancer, clustered PCDHs undergo a mechanism of long-range epigenetic silencing by hypermethylation. Results: In this study, we detected frequent methylation alterations at CpG islands associated to these clustered PCDHs in all the solid tumours analysed (colorectal, gastric and biliary tract cancers, pilocytic astrocytoma), but not hematologic neoplasms such as chronic lymphocytic leukemia. Importantly, several altered CpG islands were associated with CTCF binding sites. Interestingly, our analysis revealed a hypomethylation event in pilocytic astrocytoma, suggesting that in neuronal tissue, where PCDHs are highly expressed, these genes become hypomethylated in this type of cancer. On the other hand, in tissues where PCDHs are lowly expressed, these CpG islands are targeted by DNA methylation. In fact, PCDH-associated CpG islands resulted hypermethylated in gastrointestinal tumours. Conclusions: Our study highlighted a strong alteration of the clustered PCDHs methylation pattern in the analysed solid cancers and suggested these methylation aberrations in the CpG islands associated with PCDH genes as powerful diagnostic biomarkers.

Clustered protocadherins methylation alterations in cancer / Vega-Benedetti, A. F.; Loi, E.; Moi, L.; Blois, S.; Fadda, A.; Antonelli, M.; Arcella, A.; Badiali, M.; Giangaspero, F.; Morra, I.; Columbano, A.; Restivo, A.; Zorcolo, L.; Gismondi, V.; Varesco, L.; Bellomo, S. E.; Giordano, S.; Canale, M.; Casadei-Gardini, A.; Faloppi, L.; Puzzoni, M.; Scartozzi, M.; Ziranu, P.; Cabras, G.; Cocco, P.; Ennas, M. G.; Satta, G.; Zucca, M.; Canzio, D.; Zavattari, P.. - In: CLINICAL EPIGENETICS. - ISSN 1868-7083. - 11:(2019). [10.1186/s13148-019-0695-0]

Clustered protocadherins methylation alterations in cancer

Antonelli M.;Badiali M.;Giangaspero F.;Scartozzi M.;
2019

Abstract

Background: Clustered protocadherins (PCDHs) map in tandem at human chromosome 5q31 and comprise three multi-genes clusters: α-, β- and γ-PCDH. The expression of this cluster consists of a complex mechanism involving DNA hub formation through DNA-CCTC binding factor (CTCF) interaction. Methylation alterations can affect this interaction, leading to transcriptional dysregulation. In cancer, clustered PCDHs undergo a mechanism of long-range epigenetic silencing by hypermethylation. Results: In this study, we detected frequent methylation alterations at CpG islands associated to these clustered PCDHs in all the solid tumours analysed (colorectal, gastric and biliary tract cancers, pilocytic astrocytoma), but not hematologic neoplasms such as chronic lymphocytic leukemia. Importantly, several altered CpG islands were associated with CTCF binding sites. Interestingly, our analysis revealed a hypomethylation event in pilocytic astrocytoma, suggesting that in neuronal tissue, where PCDHs are highly expressed, these genes become hypomethylated in this type of cancer. On the other hand, in tissues where PCDHs are lowly expressed, these CpG islands are targeted by DNA methylation. In fact, PCDH-associated CpG islands resulted hypermethylated in gastrointestinal tumours. Conclusions: Our study highlighted a strong alteration of the clustered PCDHs methylation pattern in the analysed solid cancers and suggested these methylation aberrations in the CpG islands associated with PCDH genes as powerful diagnostic biomarkers.
2019
biliary tract cancer; BTC; cancer methylation alteration; chronic lymphocytic leukemia; CLL; clustered PCDH; colorectal adenoma; colorectal carcinoma; CpG islands; CRA; CRC; CTCF; gastric cancer; GC; LGG; low grade glioma; PA; pilocytic astrocytoma
01 Pubblicazione su rivista::01a Articolo in rivista
Clustered protocadherins methylation alterations in cancer / Vega-Benedetti, A. F.; Loi, E.; Moi, L.; Blois, S.; Fadda, A.; Antonelli, M.; Arcella, A.; Badiali, M.; Giangaspero, F.; Morra, I.; Columbano, A.; Restivo, A.; Zorcolo, L.; Gismondi, V.; Varesco, L.; Bellomo, S. E.; Giordano, S.; Canale, M.; Casadei-Gardini, A.; Faloppi, L.; Puzzoni, M.; Scartozzi, M.; Ziranu, P.; Cabras, G.; Cocco, P.; Ennas, M. G.; Satta, G.; Zucca, M.; Canzio, D.; Zavattari, P.. - In: CLINICAL EPIGENETICS. - ISSN 1868-7083. - 11:(2019). [10.1186/s13148-019-0695-0]
File allegati a questo prodotto
File Dimensione Formato  
Vega-Benedetti_Clustered protocadherins_2019.pdf

accesso aperto

Note: https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-019-0695-0
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 4.84 MB
Formato Adobe PDF
4.84 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1359132
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 31
social impact